Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation - A Global Prospective Single Arm Study

NCT07575269 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07575269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07575269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation - A Global Prospective Single Arm Study
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
July 7, 2026
Completion date
January 1, 2030
Enrollment
571 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation (paf), persistent atrial fibrillation